Whole genome sequence analysis of blood lipid levels in >66,000 individuals
Your Content Goes Here Calcific aortic stenosis is [...]
Diving into dominance
Your Content Goes Here For monogenic traits, dominance [...]
Genetic shields against heart disease risk
Your Content Goes Here Protein-truncating variants (PTVs) disrupt [...]
Blood Pressure Control Targets and Risk of Cardiovascular and Cerebrovascular Events After Intracerebral Hemorrhage
Your Content Goes Here Intracerebral hemorrhage (ICH) survivors [...]
Validation of a predictive model for obstructive sleep apnea in people with Down syndrome
Your Content Goes Here Detecting obstructive sleep apnea [...]
Polygenic Scores Help Reduce Racial Disparities in Predictive Accuracy of Automated Type 1 Diabetes Classification Algorithms
Your Content Goes Here Automated algorithms to identify [...]
Precise cut-and-paste DNA insertion using engineered type V-K CRISPR-associated transposases
Your Content Goes Here Genome editing technologies capable [...]
Seven technologies to watch in 2023: CRISPR anywhere
Your Content Goes Here Nature picks the top [...]
Beyond BMI to estimate disease risk
Your Content Goes Here People with the same [...]
Huntingtin turnover: modulation of huntingtin degradation by cAMP-dependent protein kinase A (PKA) phosphorylation of C-HEAT domain Ser2550
Your Content Goes Here Huntington's disease (HD) is [...]
The Center for Genomic Medicine (CGM) comprises one of the largest and most vibrant hubs of genomic medicine research in the world. The CGM includes 46 faculty collaborating to define the ‘genomic medicine cycle’ – which envisages a genomics community seeking to advance research from basic genomics research to ultimately using genome information for diagnostics and targeted therapeutics. All of our investigators are faculty at Harvard Medical School, and many members of our community are also investigators at the Broad Institute of Harvard and MIT.
